Sharon Bio-Medicine has informed that a meeting of the board of directors of the company will be held on October 22, 2012, to consider the adoption of audited balance sheet as on June 30, 2012 and statement of profit & loss for the year ended as on that date together with report of directors and auditors thereon.
Further, the board will recommend dividend on 10556900 equity shares of Rs. 10 each fully paid up for the year ended 2011-12, subject to approval of the members at the ensuing annual general meeting and the dividend, if approved at the members at the annual general meeting will be paid on or after the date of annual general meeting, the exact date will be intimated as soon as the date of annual general meeting is decided.
The above information is a part of company's filings submitted to BSE.
